Xpert Xpress SARS-CoV-2 Test

News Releases

Month Year

Month Year

Feb 15, 2017

Cepheid Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV

Providing Rapid Molecular Diagnostic Results in as little as 20 minutes
Dec 19, 2016

Cepheid Announces FDA Clearance of Next-Generation Test for MRSA Colonization

Xpert® MRSA NxG Expands Strain Coverage to Address Evolving Threats
Oct 27, 2016

30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US

Why Choose Between Fast or Accurate When You Can Have Both?
Oct 24, 2016

Cepheid Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation
Oct 5, 2016

New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring

Xpert Bladder Cancer Monitor Now Commercially Available

Show per page

Back to Top